InvestorsObserver
×
News Home

Will Trevi Therapeutics Inc (TRVI) Beat the Rest of the Stocks in the Healthcare Sector?

Friday, April 22, 2022 10:33 AM | InvestorsObserver Analysts

Mentioned in this article

Will Trevi Therapeutics Inc (TRVI) Beat the Rest of the Stocks in the Healthcare Sector?

A rating of 100 puts Trevi Therapeutics Inc (TRVI) near the top of the Healthcare sector according to InvestorsObserver. Trevi Therapeutics Inc's score of 100 means that it ranks higher than 100% of stocks in the sector. In addition, its overall score of 81 ranks it higher than 81% of all stocks.

Overall Score - 81
TRVI has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on TRVI!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 81 means the stock is more attractive than 81 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Trevi Therapeutics Inc Stock Today?

Trevi Therapeutics Inc (TRVI) stock is up 1.14% while the S&P 500 is lower by -1.17% as of 10:30 AM on Friday, Apr 22. TRVI is higher by $0.04 from the previous closing price of $3.32 on volume of 21,831 shares. Over the past year the S&P 500 has gained 5.01% while TRVI is higher by 38.84%. TRVI lost -$1.49 per share the over the last 12 months. Click Here to get the full Stock Report for Trevi Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App